Literature DB >> 2425539

Interferon induction, 2'-5' oligo A synthetase and lymphocyte subpopulations in out-patients with multiple sclerosis in a longitudinal study.

S Haahr, A Møller-Larsen, J Justesen, E Pedersen.   

Abstract

Nine patients with multiple sclerosis, four with relapsing-remitting disease, and five with chronic progressive disease, together with eight healthy control, were followed for nearly a year with monthly clinical and laboratory examinations. Alpha- and gamma-interferon was induced in lymphocytes with different viruses and PHA, no differences were found between healthy controls and multiple sclerosis patients. The alpha- and gamma-interferon induced enzyme 2'-5' oligo A synthetase in lymphocytes was found to have a tendency to be lower in multiple sclerosis patients than in healthy controls. When medians of ratios of helper/suppressor blood lymphocytes in multiple sclerosis patients were compared with healthy controls, the same results were found, although higher values of ratios were found among the patients and the highest value was found in a patient with chronic progressive disease. No correlation to disease activity could be found in interferon inductions, 2'-5' oligo A synthetase concentrations and ratios of OKT4/OKT8. In particular no change in ratio was found in relation to five exacerbations taking place in the four multiple sclerosis patients with acute relapses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425539     DOI: 10.1111/j.1600-0404.1986.tb03288.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Correlation between interferon production and clinical disease activity in patients with multiple sclerosis.

Authors:  M Dettke; P Scheidt; H Prange; H Kirchner
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

2.  Expression of biomarkers of interferon type I in patients suffering from chronic diseases.

Authors:  C Scagnolari; F Bellomi; S Trombetti; M Casato; M Carlesimo; F Bagnato; V Lavolpe; R Bruno; E Millefiorini; L Antonelli; E Girardi; O Turriziani; G Antonelli
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

3.  Diminished production of type-I interferons and interleukin-2 in patients with multiple sclerosis.

Authors:  K P Wandinger; K Wessel; P Neustock; A Siekhaus; H Kirchner
Journal:  J Neurol Sci       Date:  1997-07       Impact factor: 3.181

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.